A randomized clinical trial on the antitumoral effects of low molecular weight heparin in the treatment of esophageal cancer-Reference-Cited by-同舟云学术

A randomized clinical trial on the antitumoral effects of low molecular weight heparin in the treatment of esophageal cancer

Published:2018-10-26 Issue:4 Volume:234 Page:4191-4199
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Taghizadeh Kermani Ali¹,Hosseini Sare²,Fanipakdel Azar²,Joudi Mashhad Mona²,Akhavan Rezayat Kambiz³,Zardadi Mahdi¹,Gholami Arezoo⁴,Javadinia Seyed Alireza⁵^ORCID,Ferns Gordon A.⁶,Avan Amir⁷^ORCID

Affiliation:

1. Surgical Oncology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran

2. Cancer Research Center, Mashhad University of Medical Sciences Mashhad Iran

3. Gastroenterology and Hepatology Research Center, Emam Reza Hospital, Mashhad University of Medical Sciences Mashhad Iran

4. Department of Radiation Oncology Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran

5. Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran

6. Department of Medical Education Brighton and Sussex Medical School Brighton & Sussex Medical School, Division of Medical Education Brighton UK

7. Metabolic syndrome Research center, Mashhad University of Medical Sciences Mashhad Iran

Funder

Mashhad University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.27177

Reference49 articles.

1. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

2. Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

3. Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation;Akl E. A.;Cochrane Database of Systematic Reviews,2007

4. Parenteral anticoagulation in ambulatory patients with cancer;Akl E. A.;Cochrane Database of Systematic Reviews,2014

5. Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology;Current Oncology;2024-06-17

2. Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Concurrent Use of Crocin During Chemoradiation for Esophageal Squamous Cell Carcinoma;Cancer Investigation;2024-02-07

3. Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials;Cancers;2023-05-30

4. The Role of Nomogram Based on the Combination of Ultrasound Parameters and Clinical Indicators in the Degree of Pathological Remission of Breast Cancer;Journal of Oncology;2023-02-16

5. High Serum Squamous Cell Carcinoma Antigen Level Associated with Remission of Mild/Moderate Dysplasia of the Esophagus: A Nested Case–Control Study;Gastroenterology Research and Practice;2022-10-13